177 related articles for article (PubMed ID: 23951174)
1. quantitative assessment of the influence of cytochrome P450 1A2 gene polymorphism and colorectal cancer risk.
Zhao Y; Chen ZX; Rewuti A; Ma YS; Wang XF; Xia Q; Fu D; Han YS
PLoS One; 2013; 8(8):e71481. PubMed ID: 23951174
[TBL] [Abstract][Full Text] [Related]
2. Four polymorphisms in the cytochrome P450 1A2 (CYP1A2) gene and lung cancer risk: a meta-analysis.
Bu ZB; Ye M; Cheng Y; Wu WZ
Asian Pac J Cancer Prev; 2014; 15(14):5673-9. PubMed ID: 25081684
[TBL] [Abstract][Full Text] [Related]
3. Association between CYP1A2 and CYP1B1 polymorphisms and colorectal cancer risk: a meta-analysis.
He XF; Wei J; Liu ZZ; Xie JJ; Wang W; Du YP; Chen Y; Si HQ; Liu Q; Wu LX; Wei W
PLoS One; 2014; 9(8):e100487. PubMed ID: 25115775
[TBL] [Abstract][Full Text] [Related]
4. Current evidence on the relationship between three polymorphisms in the CYP1A2 gene and the risk of cancer.
Zhenzhen L; Xianghua L; Ning S; Zhan G; Chuanchuan R; Jie L
Eur J Cancer Prev; 2013 Nov; 22(6):607-19. PubMed ID: 23462460
[TBL] [Abstract][Full Text] [Related]
5. Association between the CYP1A2-164 A/C polymorphism and colorectal cancer susceptibility: a meta-analysis.
Hu J; Liu C; Yin Q; Ying M; Li J; Li L; Zhou CX; Wang Y
Mol Genet Genomics; 2014 Jun; 289(3):271-7. PubMed ID: 24514875
[TBL] [Abstract][Full Text] [Related]
6. Association between the CYP1A2 rs762551 Polymorphism and Bladder Cancer Susceptibility: a Meta-Analysis Based on Case-Control Studies.
Zeng Y; Jiang HY; Wei L; Xu WD; Wang YJ; Wang YD; Liu C
Asian Pac J Cancer Prev; 2015; 16(16):7249-54. PubMed ID: 26514519
[TBL] [Abstract][Full Text] [Related]
7. CYP1A2 rs762551 polymorphism contributes to cancer susceptibility: a meta-analysis from 19 case-control studies.
Wang H; Zhang Z; Han S; Lu Y; Feng F; Yuan J
BMC Cancer; 2012 Nov; 12():528. PubMed ID: 23157985
[TBL] [Abstract][Full Text] [Related]
8. Role of CYP1A2 1F polymorphism in cancer risk: evidence from a meta-analysis of 46 case-control studies.
Tian Z; Li YL; Zhao L; Zhang CL
Gene; 2013 Jul; 524(2):168-74. PubMed ID: 23628800
[TBL] [Abstract][Full Text] [Related]
9. Polymorphisms in the cytochrome P450 CYP1A2 gene (CYP1A2) in colorectal cancer patients and controls: allele frequencies, linkage disequilibrium and influence on caffeine metabolism.
Sachse C; Bhambra U; Smith G; Lightfoot TJ; Barrett JH; Scollay J; Garner RC; Boobis AR; Wolf CR; Gooderham NJ;
Br J Clin Pharmacol; 2003 Jan; 55(1):68-76. PubMed ID: 12534642
[TBL] [Abstract][Full Text] [Related]
10. Lack of association of CYP1A2-164 A/C polymorphism with breast cancer susceptibility: a meta-analysis involving 17,600 subjects.
Qiu LX; Yao L; Mao C; Yu KD; Zhan P; Chen B; Yuan H; Zhang J; Xue K; Hu XC
Breast Cancer Res Treat; 2010 Jul; 122(2):521-5. PubMed ID: 20054636
[TBL] [Abstract][Full Text] [Related]
11. Association between the CYP1A2 polymorphisms and risk of cancer: a meta-analysis.
Sun WX; Chen YH; Liu ZZ; Xie JJ; Wang W; Du YP; Chen Y; Shen XL; He XF; Wu LX; Wei W; Zhang L
Mol Genet Genomics; 2015 Apr; 290(2):709-25. PubMed ID: 25472037
[TBL] [Abstract][Full Text] [Related]
12. CYP1A2 rs762551 polymorphism contributes to risk of lung cancer: a meta-analysis.
Ma Z; Guo W; Gong T; Niu HJ; Wang RW; Jiang YG
Tumour Biol; 2014 Mar; 35(3):2253-7. PubMed ID: 24293373
[TBL] [Abstract][Full Text] [Related]
13. The effect of CYP1A1 and CYP1A2 polymorphisms on gastric cancer risk among different ethnicities: a systematic review and meta-analysis.
Xue H; Lu Y; Xue Z; Lin B; Chen J; Tang F; Huang G
Tumour Biol; 2014 May; 35(5):4741-56. PubMed ID: 24443269
[TBL] [Abstract][Full Text] [Related]
14. Effects of genetic polymorphisms of MDR1, FMO3 and CYP1A2 on susceptibility to colorectal cancer in Koreans.
Bae SY; Choi SK; Kim KR; Park CS; Lee SK; Roh HK; Shin DW; Pie JE; Woo ZH; Kang JH
Cancer Sci; 2006 Aug; 97(8):774-9. PubMed ID: 16800822
[TBL] [Abstract][Full Text] [Related]
15. Genetic polymorphisms in heterocyclic amine metabolism and risk of colorectal adenomas.
Ishibe N; Sinha R; Hein DW; Kulldorff M; Strickland P; Fretland AJ; Chow WH; Kadlubar FF; Lang NP; Rothman N
Pharmacogenetics; 2002 Mar; 12(2):145-50. PubMed ID: 11875368
[TBL] [Abstract][Full Text] [Related]
16. Meta-analysis of cytochrome P-450 2C9 polymorphism and colorectal cancer risk.
Liang S; Hu J; Cao W; Cai S
PLoS One; 2012; 7(11):e49134. PubMed ID: 23145098
[TBL] [Abstract][Full Text] [Related]
17. Polymorphisms of cytochrome P4501A2 and N-acetyltransferase genes, smoking, and risk of pancreatic cancer.
Li D; Jiao L; Li Y; Doll MA; Hein DW; Bondy ML; Evans DB; Wolff RA; Lenzi R; Pisters PW; Abbruzzese JL; Hassan MM
Carcinogenesis; 2006 Jan; 27(1):103-11. PubMed ID: 15987714
[TBL] [Abstract][Full Text] [Related]
18. The CYP1A2-164A-->C polymorphism (CYP1A2*1F) is associated with the risk for colorectal adenomas in humans.
Moonen H; Engels L; Kleinjans J; Kok Td
Cancer Lett; 2005 Nov; 229(1):25-31. PubMed ID: 16157215
[TBL] [Abstract][Full Text] [Related]
19. Lack of association between polymorphisms in the CYP1A2 gene and risk of cancer: evidence from meta-analyses.
Vukovic V; Ianuale C; Leoncini E; Pastorino R; Gualano MR; Amore R; Boccia S
BMC Cancer; 2016 Feb; 16():83. PubMed ID: 26865042
[TBL] [Abstract][Full Text] [Related]
20. Association between cytochrome P450 2C9 gene polymorphisms and colorectal cancer susceptibility: evidence from 16 case-control studies.
Wang H; Ren L; He Y; Wei Y; Chen Z; Yang W; Fu Y; Xu X; Fu W; Hu G; Lou W
Tumour Biol; 2014 May; 35(5):4317-22. PubMed ID: 24414392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
